Tilray Brands (TLRY)
(Real Time Quote from BATS)
$1.74 USD
-0.12 (-6.45%)
Updated Aug 5, 2024 03:55 PM ET
After-Market: $1.74 0.00 (0.00%) 4:18 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.74 USD
-0.12 (-6.45%)
Updated Aug 5, 2024 03:55 PM ET
After-Market: $1.74 0.00 (0.00%) 4:18 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
Tilray Brands (TLRY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Tilray Brands (TLRY) give insight into how the company performed in the quarter ended May 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tilray Brands, Inc. (TLRY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tilray Brands (TLRY) delivered earnings and revenue surprises of -100% and 1.88%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Tilray Brands (TLRY) Lined Up for Q4 Earnings: What Awaits?
by Zacks Equity Research
Tilray's (TLRY) product innovation, spanning medical cannabis formats, THC-infused beverages and pharmaceutical-grade medicines, enhances its ability to capture new market segments globally.
Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) closed at $1.89 in the latest trading session, marking a -1.56% move from the prior day.
Tilray Brands, Inc. (TLRY) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.93, marking a +1.05% move from the previous day.
Tilray Brands, Inc. (TLRY) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) closed at $1.91 in the latest trading session, marking a +1.6% move from the prior day.
Tilray Brands, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) concluded the recent trading session at $1.75, signifying a +0.87% move from its prior day's close.
Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) closed at $1.66 in the latest trading session, marking no change from the prior day.
Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) closed the most recent trading day at $1.69, moving -0.59% from the previous trading session.
Tilray Brands, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.78, representing a +0.56% change from its previous close.
Down -8.29% in 4 Weeks, Here's Why Tilray Brands (TLRY) Looks Ripe for a Turnaround
by Zacks Equity Research
Tilray Brands (TLRY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Tilray Brands, Inc. (TLRY) Stock Moves -0.55%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $1.80, indicating a -0.55% shift from the previous trading day.
International Flavors (IFF) Q1 Earnings Beat, Sales Dip Y/Y
by Zacks Equity Research
International Flavors (IFF) expects sales for 2024 to be at the higher end of $10.8-$11.1 billion.
Compared to Estimates, Tilray Brands (TLRY) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Tilray Brands (TLRY) give a sense of how the business performed in the quarter ended February 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Tilray Brands, Inc. (TLRY) Reports Break-Even Earnings for Q3
by Zacks Equity Research
Tilray Brands (TLRY) delivered earnings and revenue surprises of 100% and 5.93%, respectively, for the quarter ended February 2024. Do the numbers hold clues to what lies ahead for the stock?
Unveiling Tilray Brands (TLRY) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Tilray Brands (TLRY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended February 2024.
Village Farms (VFF) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Village Farms (VFF) delivered earnings and revenue surprises of -300% and 6%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Tilray (TLRY) Acquires Truss Beverage From Molson Coors
by Zacks Equity Research
Tilray's (TLRY) acquisition of Truss Beverage boosts its market share, broadens its product range and improves efficiency. This sets the stage for advancements in the cannabis and beverage sectors.
Wall Street's Insights Into Key Metrics Ahead of Tilray Brands, Inc. (TLRY) Q2 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Tilray Brands, Inc. (TLRY) for the quarter ended November 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Scholastic (SCHL) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Scholastic (SCHL) delivered earnings and revenue surprises of -7.55% and 10.02%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Market Edge Highlights: Canopy Growth, Tilray Brands, Constellation Brands, Innovative Industrial Properties and Jazz Pharmaceuticals
by Zacks Equity Research
Canopy Growth, Tilray Brands, Constellation Brands, Innovative Industrial Properties and Jazz Pharmaceuticals are part of the Zacks Market Edge blog.
Pot Stocks: Values or Traps?
by Tracey Ryniec
Pot stocks used to be hot but many have plunged over the last 2 years. Are there deals?
Tilray Brands (TLRY) Q1 Loss Wider, Revenues Increase Y/Y
by Zacks Equity Research
Tilray Brands (TLRY) posts wider-than-expected loss per share in first-quarter fiscal 2024.
Tilray Brands, Inc. (TLRY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Tilray Brands, Inc. (TLRY) give insight into how the company performed in the quarter ended August 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tilray Brands, Inc. (TLRY) delivered earnings and revenue surprises of -100% and 1.04%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?